Antibiotics | ESBL-producing E. coli Resistance, n (%) | ESBL-producing K. pneumoniae Resistance, n (%) | ||||
---|---|---|---|---|---|---|
Hospital (n = 28) | Community (n = 64) | p-value | Hospital (n = 24) | Community (n = 27) | p-value | |
CHL | 0 (0.0%) | 18 (28.1) | 0.001 | 04 (16.7%) | 04 (14.8%) | 0.578 |
GEN | 12 (42.9%) | 25 (39.1%) | 0.454 | 14 (58.3%) | 08 (29.6%) | 0.051 |
TET | 24 (85.7%) | 42 (65.6%) | 0.022 | 11 (45.8%) | 16 (59.3%) | 0.249 |
NAL | 22 (78.6%) | 53 (82.8%) | 0.416 | 15 (62.5%) | 16 (59.3%) | 0.521 |
CIP | 26 (92.9%) | 62 (96.9%) | 0.365 | 24 (100%) | 25 (92.6%) | 0.491 |
SXT | 22(78.6%) | 39 (60.9%) | 0.999 | 22 (91.7%) | 25 (92.6%) | 0.999 |